Noranelle (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol and Levonorgestrel, the active ingredients in Noranelle, are a combined oral contraceptive presented as an oral tablet for oral use. They are prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.

GNH USA supplies Noranelle as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for global distribution. Manufacturing follows strict GMP conditions to ensure product consistency. All batches undergo rigorous quality testing before release.

Noranelle, a combined oral contraceptive, is used in the hormonal regulation pathway to prevent pregnancy.

- Prevention of pregnancy: provides reliable contraception for women of childbearing potential. - Contraception: reduces the risk of unintended pregnancy through ovulation suppression. - Menstrual cycle regulation: may help achieve more regular periods and reduce dysmenorrhea in some users.

Noranelle may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea - Breast tenderness - Headache - Spotting between periods

Serious or Rare Side Effects: - Deep vein thrombosis - Pulmonary embolism - Stroke - Severe allergic reaction (anaphylaxis)

Before prescribing Noranelle, clinicians should consider several safety factors. - Assess thromboembolic risk: avoid use in women with a history of blood clots. - Screen for hypertension: contraindicated in uncontrolled high blood pressure. - Avoid smoking: especially in women over 35 years of age. - Evaluate liver function: not recommended in severe hepatic disease. - Review concomitant medications: check for interactions that may reduce efficacy. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Noranelle can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive effectiveness. - Rifampicin antibiotic: decreases hormone levels, increasing risk of pregnancy. - Protease inhibitor antiretrovirals (e.g., ritonavir): can lower contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., ketoconazole): may increase hormone concentrations, raising side‑effect risk. - St. John’s wort herbal supplement: may reduce contraceptive effectiveness. - Diuretics (e.g., thiazides): may exacerbate blood pressure changes.